Korean J Dermatol.
2018 Feb;56(2):91-98.
Allergen-specific Immunotherapy in Patients with Atopic Dermatitis
- Affiliations
-
- 1Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea. kwanglee@yuhs.ac
Abstract
- Allergy specific immunotherapy (SIT) has been established as an effective treatment in patients with allergic asthma and rhinitis. Although its efficacy has been relatively controversial in patients with atopic dermatitis, recent controlled trials and meta-analyses have reported significant improvement in subjective symptoms in some patients with moderate-to-severe atopic dermatitis. There are a few limitations with SIT safety and patient compliance. Efforts are being made to overcome these limitations, including using recombinant allergens and adjuvants, as well as different routes of administration, such as transdermal delivery. Herein, we review the mechanism of SIT in patients with atopic dermatitis, clinical trial results, its use in clinical practice, limitations, and future direction.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Two Cases of Atopic Dermatitis Improved by Combination Treatment of Allergen-Specific Immunotherapy and Histamine-Immunoglobulin Complex
- Dermatophagoides Farinae-specific IgE and IgG4 Antibodies in Atopic Dermatitis Patients
- Treatment of Patients with Refractory Atopic Dermatitis Sensitized to House Dust Mites by Using Sublingual Allergen Immunotherapy
- Specific Immunotherapy in Atopic Dermatitis
- Relationship between Allergen Sensitization and Frequency of Asthma in Preschool Atopic Dermatitis Children
